The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
Abstract
In patients with Parkinson's disease, the therapeutic efficacy of L-DOPA medication is gradually lost over time, and abnormal involuntary movements, dyskinesias, gradually emerge as a prominent side-effect in response to previously beneficial doses of the drug. Here we show that dyskinesia induced by chronic L-DOPA treatment in rats with 6-hydroxydopamine-induced lesions of the nigrostriatal dopamine pathway is critically dependent on the integrity and function of the serotonergic system. Removal of the serotonin afferents, or dampening of serotonin neuron activity by 5-HT1A and 5-HT1B agonist drugs, resulted in a near-complete block of the L-DOPA-induced dyskinesias, suggesting that dysregulated dopamine release from serotonin terminals is the prime trigger of dyskinesia in the rat Parkinson's disease model. In animals with complete dopamine lesions, the spared serotonin innervation was unable to sustain the therapeutic effect of L-DOPA, suggesting that dopamine released as a 'false transmitter' from serotonin terminals is detrimental rather than beneficial. The potent synergistic effect of low doses of 5-HT1A and 5-HT1B agonists to suppress dyskinesia, without affecting the anti-parkinsonian effect of L-DOPA in presence of spared dopamine terminals, suggests an early use of these drugs to counteract the development of dyskinesia in Parkinson's disease patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists
Sprouse, J. S., & Aghajanian, G. K. (1987) · Synapse · doi:10.1002/syn.890010103 · Cited by 845
Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Self-citationOlsson, M., Nikkhah, G., Bentlage, C., & Bjorklund, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03863.1995 · Cited by 625
Self-citationBiochemical aspects of Parkinson's disease
Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 564
Riad, M., Garcia, S., Watkins, K. C., Jodoin, N., Doucet, �., Langlois, X., El Mestikawy, S., Hamon, M., & Descarries, L. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000207)417:2<181::aid-cne4>3.0.co;2-a · Cited by 513
Winkler, C., Kirik, D., Björklund, A., & Cenci, M. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0499 · Cited by 430
Self-citationKirik, D., Rosenblad, C., Björklund, A., & Mandel, R. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04686.2000 · Cited by 428
Self-citationChalmers, D. T., & Watson, S. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90748-k · Cited by 387
L-Dopa: Effect on Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of Mice
Everett, G. M., & Borcherding, J. W. (1970) · Science · doi:10.1126/science.168.3933.849 · Cited by 332
L-Dopa-Induced Release of Cerebral Monoamines
Ng, K. Y., Chase, T. N., Colburn, R. W., & Kopin, I. J. (1970) · Science · doi:10.1126/science.170.3953.76 · Cited by 331
Tanaka, H., Kannari, K., Maeda, T., Tomiyama, M., Suda, T., & Matsunaga, M. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00034 · Cited by 302
Bjömorklnd, A., Baumgarten, H. G., & Rensch, A. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb03878.x · Cited by 299
Goetz, C. G., Damier, P., Hicking, C., Laska, E., Müller, T., Olanow, C. W., Rascol, O., & Russ, H. (2007) · Movement Disorders · doi:10.1002/mds.21226 · Cited by 260
Chang, J.-W., Wachtel, S. R., Young, D., & Kang, U.-J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00217-6 · Cited by 248
Lavoie, B., & Parent, A. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902990102 · Cited by 239
Sari, Y., Miquel, M.-C., Brisorgueil, M.-J., Ruiz, G., Doucet, E., Hamon, M., & Vergé, D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00256-5 · Cited by 222
Lee, C. S. (2000) · Brain · doi:10.1093/brain/123.7.1365 · Cited by 212
Hajós, M., Hajós‐Korcsok, É., & Sharp, T. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702510 · Cited by 210
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys
Konitsiotis, S., Blanchet, P. J., Verhagen, L., Lamers, E., & Chase, T. N. (2000) · Neurology · doi:10.1212/wnl.54.8.1589 · Cited by 201
Goodwin, G. M., De Souza, R. J., Green, A. R., & Heal, D. J. (1987) · Psychopharmacology · doi:10.1007/bf00216019 · Cited by 200
Arai, R., Karasawa, N., Geffard, M., & Nagatsu, I. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11817-g · Cited by 185
Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys
Blanchet, P. J., Konitsiotis, S., & Chase, T. N. (1998) · Movement Disorders · doi:10.1002/mds.870130507 · Cited by 185
Olanow, C. W., Damier, P., Goetz, C. G., Mueller, T., Nutt, J., Rascol, O., Serbanescu, A., Deckers, F., & Russ, H. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200403000-00003 · Cited by 175
The site of dopamine formation in rat striatum after L-dopa administration.
Hefti, F. F., Melamed, E., & Wurtman, R. J. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32511-5 · Cited by 166
Effects of serotonin 5‐HT1A agonist in advanced Parkinson's disease
Bara‐Jimenez, W., Bibbiani, F., Morris, M. J., Dimitrova, T. D., Sherzai, A., Mouradian, M. M., & Chase, T. N. (2005) · Movement Disorders · doi:10.1002/mds.20370 · Cited by 160
Arai, R., Karasawa, N., Geffard, M., Nagatsu, T., & Nagatsu, I. (1994) · Brain Research · doi:10.1016/0006-8993(94)91511-3 · Cited by 156
Nicholson, S. L., & Brotchie, J. M. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.9.s3.1.x · Cited by 146
Miller, D. W., & Abercrombie, E. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721516.x · Cited by 138
Kannari, K., Yamato, H., Shen, H., Tomiyama, M., Suda, T., & Matsunaga, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00184.x · Cited by 133
Ceci, A., Baschirotto, A., & Borsini, F. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90177-5 · Cited by 128
Maeda, T., Nagata, K., Yoshida, Y., & Kannari, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.019 · Cited by 126
The role of 5‐HT1B receptors in the regulation of serotonin cell firing and release in the rat brain
Adell, A., Celada, P., & Artigas, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00550.x · Cited by 123
Presynaptic mechanisms of motor fluctuations in Parkinson’s disease: a probabilistic model
de la Fuente‐Fernández, R., Schulzer, M., Mak, E., Calne, D. B., & Stoessl, A. J. (2004) · Brain · doi:10.1093/brain/awh102 · Cited by 123
Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex
Casanovas, J. M., Hervás, I., & Artigas, F. (1999) · Neuroreport · doi:10.1097/00001756-199905140-00010 · Cited by 120
Iravani, M., Tayarani-Binazir, K. A., Chu, W. B., Jackson, M., & Jenner, P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110429 · Cited by 115
Mura, A., Jackson, D., Manley, M. S., Young, S. J., & Groves, P. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)01104-8 · Cited by 112
Knobelman, D. A., Kung, H. F., & Lucki, I. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35396-0 · Cited by 103
Goodwin, G. M., Souza, R. J. D., Wood, A. J., & Green, A. R. (1986) · Psychopharmacology · doi:10.1007/bf00174066 · Cited by 96
Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum
Lopez, A., Muñoz, A., Guerra, M. J., & Labandeira-García, J. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00588-1 · Cited by 91
The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice
Yamada, J., Sugimoto, Y., & Horisaka, K. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90205-1 · Cited by 84
Arai, R., Karasawa, N., & Nagatsu, I. (1996) · Brain Research · doi:10.1016/0006-8993(95)01281-8 · Cited by 81
López-Real, A. M., Rodríguez‐Pallares, J., Guerra, M. J., & Labandeira-García, J. L. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02291-1 · Cited by 75
Carey, R. J., DePalma, G., Damianopoulos, E. N., M�ller, C., & Huston, J. P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1917-4 · Cited by 74
Effects of sarizotan on the corticostriatal glutamate pathways
Antonelli, T., Fuxé, K., Tomasini, M. C., Bartoszyk, G. D., Seyfried, C. A., Tanganelli, S., & Ferraro, L. (2005) · Synapse · doi:10.1002/syn.20195 · Cited by 74
Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
Hollister, A. S., Breese, G. R., & Mueller, R. A. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31520-x · Cited by 68
Ultrastructure of Secretory and High-Polymer Serum Immunoglobulin A of Human and Rabbit Origin
Svehag, S., & Bloth, B. (1970) · Science · doi:10.1126/science.168.3933.847 · Cited by 66
Effects of L-Dopa on Efflux of Cerebral Monoamines from Synaptosomes
Ng, K. Y., Colburn, R. W., & Kopin, I. J. (1971) · Nature · doi:10.1038/230331a0 · Cited by 57
Jackson, M. J., Al‐Barghouthy, G., Pearce, R. K. B., Smith, L. A., Hagan, J. J., & Jenner, P. G. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.07.015 · Cited by 50
Mignon, L., & Wolf, W. A. (2005) · Neuroreport · doi:10.1097/00001756-200505120-00009 · Cited by 48
Carey, R. J., DePalma, G., Damianopoulos, E. N., Hopkins, A., Shanahan, A., Müller, C. P., & Huston, J. P. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.091 · Cited by 48
Carey, R. J., DePalma, G., Damianopoulos, E. N., Shanahan, A., Müller, C. P., & Huston, J. P. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.012 · Cited by 38
Tryptophan-deficient diet increases the neurochemical and behavioral response to amphetamine
Carta, M., Fadda, F., & Stancampiano, R. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.118 · Cited by 13
Self-citation
Cited by
Functional Neuroanatomy of the Basal Ganglia
Lanciego, J. L., Luquin, N., & Obeso, J. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009621 · Cited by 833
Molecular mechanisms of L-DOPA-induced dyskinesia
Jenner, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2471 · Cited by 523
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Self-citationMendez, I., Viñuela, A., Astradsson, A., Mukhida, K., Hallett, P., Robertson, H., Tierney, T., Holness, R., Dagher, A., Trojanowski, J. Q., et al. (2008) · Nature Medicine · doi:10.1038/nm1752 · Cited by 443
Systemic administration of epothilone B promotes axon regeneration after spinal cord injury
Ruschel, J., Hellal, F., Flynn, K. C., Dupraz, S., Elliott, D. A., Tedeschi, A., Bates, M., Sliwinski, C., Brook, G., Dobrindt, K., et al. (2015) · Science · doi:10.1126/science.aaa2958 · Cited by 432
Metadata
- Authors
- Carta, M., Carlsson, T., Kirik, D., & Bjorklund, A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-29
- Volume
- 130
- Issue
- 7
- Pages
- 1819-1833
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2097863680
- Cited by
- 636
- References
- 53
- FWCI
- 26.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.